A comparison of clinical pharmacist management of type 2 diabetes versus usual care in a federally qualified health center.
Rhianna M TuchschererEmanuela V MooneyJoseph J SaseenSarah J BillupsPublished in: Pharmacy practice (2019)
Pharmacotherapy approaches to managing patients with uncontrolled type 2 diabetes varied between clinical pharmacists and other clinician providers. For patients already on basal insulin, clinical pharmacists were more likely to intensify therapy with the addition of non-basal insulin, including more frequent initiation of prandial insulin and by adding newer antihyperglycemic agents.
Keyphrases
- type diabetes
- glycemic control
- healthcare
- end stage renal disease
- cardiovascular disease
- public health
- mental health
- insulin resistance
- chronic kidney disease
- ejection fraction
- primary care
- metabolic syndrome
- prognostic factors
- bone marrow
- social media
- peritoneal dialysis
- health insurance
- pain management
- risk assessment
- affordable care act
- health promotion
- patient reported